Eosinophilic gastroenteritis (EGE) is characterized by dense eosinophilic inflammation of one or several digestive tract sections. The symptoms include abdominal pain, weight loss, vomiting and ...

Welcome to the University of Utah Adult Eosinophilic Gastrointestinal Disease Clinic (EGID) where we specialize in the care and treatment of patients with conditions such as eosinophilic esophagitis, ...

Eosinophilic GI diseases (EGIDs) often overlap with other eosinophil-associated diseases (EADs), which leads to greater health care costs, according to an analysis of the U.S. Optum Clinformatics ...

Please provide your email address to receive an email when new articles are posted on . A food allergy free diet may effectively improve histologic, molecular, endoscopic and symptomatic disease ...

After years of dependence on systemic corticosteroids, ruxolitinib treatment was effective for an adolescent patient with graft-versus-host disease (GVHD) who was initially thought to have ...

These rare, chronic relapsing conditions are primarily associated with eosinophilic tissue inflammation. The Food and Drug Administration (FDA) has granted Orphan Drug designations to benralizumab for ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — A novel therapeutic agent helped reduce eosinophil counts and improve symptoms in patients with ...

An article published in the journal Gastroenterology & Hepatology highlights recent updates to eosinophilic gastrointestinal disease nomenclature, as well as updates related to diagnosis, pathogenesis ...

The pathogenesis of eosinophilic gastroenteritis (EGE), a chronic inflammatory disease characterized by eosinophil infiltration in the gastrointestinal tract, is still not well understood.

Cincinnati Children's Hospital Medical Center has received a 5-year, $7.57 million grant renewal from the National Institutes of Health (NIH) to continue leading a consortium of organizations from ...

Physicians and patient advocates are sounding the alarm after the NIH abruptly withdrew a grant renewal application for the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), the ...

Researchers at Children's Hospital of Philadelphia (CHOP) identified a potential new therapeutic target for eosinophilic esophagitis (EoE), a chronic allergic inflammatory disease of the esophagus.